Please Wait
Applying Filters...
menu
    • menu
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Fishfa Biogenics: Renowned Manufacturer, & Exporter of Tacrolimus & Mupirocin API.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Soticlestat

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: Ov935, 1429505-03-2, Tak-935, Soticlestat [inn], Soticlestat [usan], Ov-935
    Molecular Formula
    C23H23N3O2
    Molecular Weight
    373.4  g/mol
    InChI Key
    XKUZMIUSBMCVPP-UHFFFAOYSA-N
    FDA UNII
    1766MU795L
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (4-benzyl-4-hydroxypiperidin-1-yl)-(2-pyridin-4-ylpyridin-3-yl)methanone
    2.1.2 InChI
    InChI=1S/C23H23N3O2/c27-22(20-7-4-12-25-21(20)19-8-13-24-14-9-19)26-15-10-23(28,11-16-26)17-18-5-2-1-3-6-18/h1-9,12-14,28H,10-11,15-17H2
    2.1.3 InChI Key
    XKUZMIUSBMCVPP-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    C1CN(CCC1(CC2=CC=CC=C2)O)C(=O)C3=C(N=CC=C3)C4=CC=NC=C4
    2.2 Other Identifiers
    2.2.1 UNII
    1766MU795L
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. (4-benzyl-4-hydroxy-1-piperidinyl)(2,4'-bipyridin-3-yl)methanone

    2. Ov-935

    3. Ov935

    2.3.2 Depositor-Supplied Synonyms

    1. Ov935

    2. 1429505-03-2

    3. Tak-935

    4. Soticlestat [inn]

    5. Soticlestat [usan]

    6. Ov-935

    7. Tak935

    8. Soticlestat (usan)

    9. 1766mu795l

    10. (4-benzyl-4-hydroxypiperidin-1-yl)-(2-pyridin-4-ylpyridin-3-yl)methanone

    11. [4-oxidanyl-4-(phenylmethyl)piperidin-1-yl]-(2-pyridin-4-ylpyridin-3-yl)methanone

    12. Soticlestat [usan:inn]

    13. Chembl4298172

    14. Schembl14841089

    15. Unii-1766mu795l

    16. Gtpl11517

    17. Who 10844

    18. Hy-109123

    19. Cs-0078356

    20. D11590

    21. (4-benzyl-4-hydroxypiperidin-1-yl) (2,4'-bipyridin-3-yl)methanone

    22. (4-benzyl-4-hydroxypiperidin-1-yl)(2,4'-bipyridin-3-yl)methanone

    23. [2,4'-bipyridin]-3-yl(4-benzyl-4-hydroxypiperidin-1-yl)methanone

    24. 2,4'-bipyridin-3-yl(4-benzyl-4-hydroxypiperidin-1-yl)methanone

    25. Ybs

    2.4 Create Date
    2014-04-21
    3 Chemical and Physical Properties
    Molecular Weight 373.4 g/mol
    Molecular Formula C23H23N3O2
    XLogP32.5
    Hydrogen Bond Donor Count1
    Hydrogen Bond Acceptor Count4
    Rotatable Bond Count4
    Exact Mass373.17902698 g/mol
    Monoisotopic Mass373.17902698 g/mol
    Topological Polar Surface Area66.3 Ų
    Heavy Atom Count28
    Formal Charge0
    Complexity506
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Indication

    Treatment of Chromosome 15q Duplication Syndrome, Treatment of Cyclin-Dependent Kinase-Like 5 deficiency disorder

    Treatment of Dravet syndrome, Treatment of Lennox-Gastaut syndrome